Revenue Growth Outlook Market signals show Myriad Genetics is driving efficiency through AI-enabled revenue-cycle tools and organizational initiatives, presenting an opportunity to offer integrated financial analytics, RCM optimization, and payer-reimbursement workflow solutions to further enhance profitability.

Reimbursement Pressure We should address ongoing reimbursement and prenatal volume headwinds in hereditary cancer testing, offering services that strengthen coding, claims analytics, and payer negotiation support to help stabilize revenue and protect margins.

AI and Automation Myriad is investing in AI-driven outputs, prompts refinement, and intelligent document processing tools like Image Genius; high-potential upsell includes advanced AI copilots for lab operations, automated data extraction from pathology reports, and streamlined revenue-cycle documentation.

Precision Medicine Focus As a leader in molecular diagnostics and precision medicine, there is an opportunity to propose partnerships around companion diagnostics, integrated care pathways, and data-driven risk assessment solutions that align with Myriad’s disease-risk testing portfolio.

Technology Stack Fit Myriad’s tech landscape (SAP, Osano, Wistia, HubSpot, SailPoint, Microsoft Intune) suggests value in security, data integration, and customer lifecycle optimization using enterprise-scale analytics, CRM automation, and secure data access solutions to boost efficiency and data governance.